This article discusses the recent approval of the first over-the-counter naloxone nasal spray for use in reversing opioid overdoses. The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) naloxone nasal spray, Narcan, to help prevent opioid overdoses. The nasal spray is intended for use in adults and adolescents, and the FDA […]
FDA Approves OTC Naloxone Read More »
The ADA has issued a FAQ (frequently asked questions) providing additional information regarding the 2022 Omnibus Bill with provisions for the MATE Act – which included a controlled substance education requirement for continuing DEA registration. The FAQ suggests further information and guidance will be forthcoming by the end of March. The Act contains exclusions and
It has come to our attention a little known provision of the federal omnibus bill approved in the waning hours of 2022 included a requirement that could impact your practice if not properly managed. The Medication Access and Training Expansion (MATE) Act, which aims to improve access to medications and expand training for healthcare professionals
A recent CDC analysis shows that antihistamines, particularly first-generation H1 subtype antihistamines like diphenhydramine, play a role in drug overdoses. Opioids were involved in most cases, and naloxone may not work with antihistamines. Continual monitoring is important.
Antihistamines A common Contributor In Opioid Overdose Deaths? Read More »
Healthcare professionals have been alerted by the FDA to the dangers of patients being exposed to xylazine, a veterinary sedative, in illicit drugs. The FDA advises healthcare professionals to report any adverse events related to xylazine.
Fentanyl is now the leading cause of overdose deaths among young people, with a nearly 500% increase in deaths among those aged 25 and under. Learn more.
For over two decades, the opioid crisis in the United States has been an urgent health care emergency. Initially driven by over-prescription of pharmaceutical opioids, this has evolved into a “fourth wave” marked by poly-substance use, combining opioids and methamphetamine, resulting in record-high deaths year after year. The Covid-19 pandemic has made the situation even
The Fourth Wave Of The Opiate Crisis Read More »
In an online-first article in Anesthesia News a study presented at the 2022 annual meeting of the American Society of Anesthesiologists found adults who use cannabis have more pain after surgery and consume more opiates than those who don’t use the drug, Elyad Ekrami, MD, a lead author of the study and clinical research fellow
Pre-op Cannibis Use Associated More Post-Op Pain, Opiate Use Read More »
In his tweet “Things I learned working as an Assistant US Attorney prosecuting violent crime in St Louis, America’s murder capital” former federal prosecutor Will Scharf called out in one fell-swoop the mainstream media for under-reporting, Washington for it’s open border policies, and the Chinese Communist Party for their complicity in the fentanyl epidemic raging
Former Federal Prosecutor States Opiate Crisis Far Worse… Read More »
On Thursday, November 3, 2022, the CDC released it’s most recent recommendations for the prescribing of opioids for acute, subacute, and chronic pain. The new guidelines provide 12 recommendations relating to the use of opioids and mostly favor a more individualized approach. However, the CDC issued a guideline much stronger than the 2016 version defining
2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain Read More »
Main Menu
User Menu
